Zantac Users Should Consider Safer Alternative Drugs
The FDA has issued a list of drugs they have preliminarily tested and found to be safe from elevated levels of NDMA
Wednesday, July 1, 2020 - Heartburn and acid-reflux sufferers that have been left in the lurch by the recall of Zantac, the world's best-selling heartburn medicine, have several alternatives to choose from to alleviate the painful burning in their stomach and chest. Over the counter and prescription medication, Zantac was voluntarily withdrawn from the market because it contains unsafe levels of NDMA, a by-product of manufacturing rocket fuel, and a carcinogen given to lab test animals to induce tumors to be studied. Zantac was removed from the shelves of pharmacies like Walmart, Walgreens, Rite Aid, and CVS. The US Food and Drug Administration (FDA) has produced a list of Zantac-replacement drugs that were recently tested and found to be safe. The FDA recommends Zantac users to consider taking Pepcid (famotidine), Tagamet (cimetidine), Nexium (esomeprazole), Prevacid (lansoprazole) or Prilosec (omeprazole), all of which have had favorable test results.
According to Wikipedia, "Pepcid, (Famotidine), is a medication that decreases stomach acid production. It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It is taken by mouth or by injection into a vein. It begins working within an hour. Tagamet, (cimetidine), is a histamine H₂ receptor antagonist that inhibits stomach acid production. Nexium (esomeprazole), reduces stomach acid. It is used to treat gastroesophageal reflux disease, peptic ulcer disease, and Zollinger-Ellison syndrome. Effectiveness is similar to other proton pump inhibitors. It is taken by mouth or injection into a vein." Proton Pump Inhibitor (PPI) drugs work by shutting the release of digestive acids in the stomach. They are not intended for immediate relief and can take up to 4 days to become fully effective. PPI drugs are required to be taken daily to be effective and therein may lie the problem. Zantac users have filed suit against Sanofi, the maker of Zantac, alleging that taking the drug regularly for an extended time exposed them to carcinogenic levels of NDMA. Zantac users have allegedly developed cancer of the stomach, bladder, esophagus, prostate, pancreas, breast, and other forms of cancer. Many have hired Zantac Cancer Attorneys to file a claim against Sanofi for failing to warn them of the dangers of taking the drug.
Zantac has been available to the public since the 1980s and sales have exceeded $10 billion per year for over a decade. The recall deals a severe blow to Sanofi, the maker of Zantac, and also generic ranitidine manufacturers Generic drugmakers Perrigo, Novartis, and Apotex which all followed suit and immediately recalled their heartburn drugs. NDMA is an environmental contaminant found in water and most foods at levels assumed to be safe for human consumption. Researchers think that heating ranitidine to levels that mimic those found in the human stomach can cause ranitidine to break down and NDMA to increase to levels in the millions of nanograms per dosage. The allowable FDA level of NDMA is only 96 nanograms.
More Recent Heartburn MedicineLawsuit News:
- Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
- Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
- Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
- The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
- Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
- Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
- Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
- A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
- Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
- Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
- Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
- Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
- The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
- Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
- Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
- Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
- Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
- Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
- Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
- Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022
Lawyers for Zantac Heartburn Medicine Lawsuits
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.